This activity is supported by educational grants from:
- Abbott's molecular business
- Adaptive Biotechnologies
- AstraZeneca
- BeiGene, Ltd.
- Blueprint Medicines
- Daiichi Sankyo
- Deciphera Pharmaceuticals
- Eisai
- Exact Sciences
- Genentech, a member of the Roche Group
- Gilead Sciences
- GlaxoSmithKline
- GRAIL, Inc.
- Ipsen Biopharmaceuticals, Inc.
- Jazz Pharmaceuticals, Inc.
- Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
- Lilly
- Olympus Corporation of the Americas
- Novartis
- Pfizer
- Puma Biotechnology
- Seagen Inc. formerly Seattle Genetics
- Taiho Oncology, Inc.
- TeSera Therapeutics
This activity is supported by independent medical education grants from:
- Bristol Myers Squibb
- Illumina, Inc.
- Regeneron Pharmaceuticals, Inc and Sanofi Genzyme
This activity is supported by independent educational grants from:
- AbbVie
- Astellas
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Incyte
- Merck & Co., Inc.
This activity is supported by educational funding provided by Amgen
This educational activity is supported by a medical education grant from Exelixis, Inc. and Karyopharm® Therapeutics
This project has been made possible in part by a grant from Varian Medical Systems/Global Medical Education Grant Program